Home

ticker
ticker

Flower Alley Trending Upward

With over 580,000 TrueNicks reports generated so far in 2012, it's always interesting to look at what the numbers are telling us. Logically, the number of TrueNicks reports per stallion fluctuates according to the stallion's popularity among breeders. For example, see the chart below and notice what happened on the week ending 3/25, when Tapit (TrueNicks,SRO) was announced as Zenyatta's next mate. Tapit accounted for over 2% of all TrueNicks reports run that week, quite a staggering figure considering there are over 700 complimentary stallions available on TrueNicks.

Selected stallions in 2012 (click to enlarge)

The most popular stallion so far in 2012 by number of reports is Bernardini (TrueNicks,SRO). No surprise here, as he's the most commercial young stallion at the moment.

Also included on this chart is the ultra-consistent City Zip (TrueNicks,SRO). This stallion always brings in a high number of reports, and he does it in a manner similar to his stud record—not much volatility, just consistent results.

A big winner in 2012 is Flower Alley (TrueNicks,SRO), whose popularity is mostly due to Kentucky Derby and Preakness (both gr. I) winner I'll Have Another, who goes for the Triple Crown on June 9. In the chart above, you can see spikes in Flower Alley's report volume following I'll Have Another's wins in the Santa Anita Derby (gr. I), Kentucky Derby, and Preakness.

Proud Citizen (TrueNicks,SRO) has had a monster 2012. Not only did he sire Kentucky Oaks (gr. I) winner Believe You Can, but also Peter Pan (gr. II) winner Mark Valeski, Spiral (gr. II) winner Went the Day Well, Santa Ana (gr. II) winner Vamo a Galupiar, and Trickmeister, who beat Bernardini's Stay Thirsty earlier this month in the Vanlandingham Stakes.

You can monitor current popular stallions on our TrueNicks ticker in the upper right corner of TrueNicks.com pages. The ticker shows rolling seven-day leaders in number of reports overall and in three stud fee categories.

Filed under: ,

comments powered by Disqus